Table 2 Univariate analysis of relationship between peripheral hematology and treatment effect

WBC (× 10⁹/L)

(6.37 ± 3.27)

(6.07 ± 3.02)

 − 0.048

0.962

(6.31 ± 3.09)

(5.95 ± 3.04)

 − 1.846

0.065

ANC (× 10⁹/L)

(4.44 ± 3.48)

(4.00 ± 2.45)

 − 0.350

0.726

(4.50 ± 1.57)

(1.03 ± 2.65)

 − 1.744

0.081

ALC (× 10⁹/L)

(1.16 ± 1.11)

(1.34 ± 0.78)

 − 1.206

0.228

(1.35 ± 0.80)

(1.25 ± 0.84)

 − 0.669

0.503

AMC (× 10⁹/L)

(0.44 ± 0.26)

(0.39 ± 0.24)

 − 0.519

0.604

(0.40 ± 0.29)

(0.37 ± 0.23)

 − 0.622

0.534

RBC (× 10⁹/L)

(4.91 ± 11.00)

(4.56 ± 7.36)

 − 0.025

0.025

(4.27 ± 0.55)*

(4.06 ± 0.82)

 − 2.681

0.007

Hb (g/L)

(122.30 ± 17.83)

(129.00 ± 26.00)

 − 2.401

0.016

(134.0 ± 26.8)

(125.95 ± 24.7)

 − 2.863

0.004

PLT (× 10⁹/L)

(207.50 ± 122)

(248.61 ± 94)

 − 0.601

0.548

(223.0 ± 87)

(229.50 ± 103)

 − 0.325

0.746

AEC (× 10⁹/L)

(0.07 ± 0.09)

(0.10 ± 0.12)

-2.068

0.039

(0.12 ± 0.16)

(0.09 ± 0.11)

 − 1.068

0.286

ABC (× 10⁹/L)

(0.02 ± 0.03)

(0.04 ± 0.02)

 − 0.386

0.700

(0.03 ± 0.02)

(0.02 ± 2.65)

 − 1.563

0.118

PAB^# (mg/L)

(200.67 ± 73.36)^*

(210.84 ± 69.22)^*

 − 1.398

0.163

(214.47 ± 29.03)*

(205.24 ± 72.30)*

 − 0.970

0.334

ALB (g/L)

(40.15 ± 3.36)^*

(41.10 ± 4.75)

 − 2.600

0.009

(40.52 ± 3.88)*

(40.75 ± 5.38)

 − 0.305

0.761

NLR

(3.49 ± 2.72)

(3.14 ± 2.81)

 − 1.437

0.151

(3.30 ± 3.28)

(3.25 ± 2.49)

 − 0.458

0.647

PLR

(161.10 ± 124.54)

(183.87 ± 141.75)

 − 0.436

0.663

(171.21 ± 133.24)

(175.38 ± 131.65)

 − 0.009

0.993

MLR

(0.33 ± 0.23)

(0.30 ± 0.25)

 − 1.832

0.067

(0.29 ± 0.33)

(0.30 ± 0.23)

 − 0.455

0.649

SIRI

(1.53 ± 1.58)

(1.13 ± 1.73)

 − 1.421

0.155

(1.40 ± 1.94)

(1.20 ± 1.50)

 − 0.577

0.564

NER

(57.21 ± 96.06)

(40.90 ± 63.54)

 − 2.480

0.013

(39.92 ± 91.85)

(48.37 ± 68.23)

 − 0.319

0.750

PNI

(46.01 ± 5.33)^*

(47.29 ± 6.05)

 − 2.422

0.015

(47.75 ± 5.29)*

(47.35 ± 6.20)

 − 0.572

0.568